Gujarat Kidney And Super Speciality Limited
BSE: GKSL · Hospital
Snapshot
Unlock Gujarat Kidney And Super Speciality Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Gujarat Kidney and Super Speciality Limited is a regional healthcare provider based in central Gujarat. The company operates a chain of mid-sized hospitals that offer a range of secondary and tertiary care services.
Business Model
The company generates revenue by providing multispeciality healthcare services through its hospital network. Its business model focuses on delivering clinical care across secondary and tertiary medical segments.
Growth Outlook
Growth is expected to be driven by the expansion of its regional hospital network and the increasing demand for specialized healthcare services in central Gujarat.
Key Risks
- Regulatory Compliance. The healthcare sector is subject to stringent government regulations and licensing requirements that may impact operational costs.
- Geographic Concentration. Operating primarily in central Gujarat exposes the company to regional economic fluctuations and localized competition.
- Talent Acquisition. The ability to attract and retain qualified medical professionals and specialists is critical to maintaining service quality.
- Operational Costs. Rising costs associated with medical equipment, pharmaceuticals, and infrastructure maintenance could pressure profit margins.
Start your research today
Unlock AI insights, financials, peers and live data on Gujarat Kidney And Super Speciality Limited and 5,000+ companies — free.
Peers · Hospital
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Gujarat Kidney And Super Speciality LimitedGKSL | ₹1,401 Cr | — | — | — | 33.0% | — | — | — |
Dr Agarwals Eye Hospital LimitedDRAGARWQ | ₹2,514 Cr | 32.5× | 16.34 | 20.0% | 31.9% | 27.4% | 18.9% | +3.9% |
Shalby Ltd.SHALBY | ₹1,573 Cr | 38.2× | 12.30 | 6.5% | 14.5% | 3.8% | 7.8% | -49.4% |
Gpt Healthcare Ltd.GPTHEALTH | ₹1,325 Cr | 26.3× | 13.73 | 18.1% | 19.8% | 18.3% | 20.0% | +2.6% |
Rays of Belief LimitedMOMSBELIEF | ₹476 Cr | — | — | — | 11.3% | — | — | — |
Asarfi Hospital Ltd.ASARFI | ₹334 Cr | — | — | — | 20.0% | — | — | +29.4% |
As of Mar 2026
Financials
Gujarat Kidney And Super Speciality Limited
BSE: GKSL · Hospital
Snapshot
Unlock Gujarat Kidney And Super Speciality Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Gujarat Kidney and Super Speciality Limited is a regional healthcare provider based in central Gujarat. The company operates a chain of mid-sized hospitals that offer a range of secondary and tertiary care services.
Business Model
The company generates revenue by providing multispeciality healthcare services through its hospital network. Its business model focuses on delivering clinical care across secondary and tertiary medical segments.
Growth Outlook
Growth is expected to be driven by the expansion of its regional hospital network and the increasing demand for specialized healthcare services in central Gujarat.
Key Risks
- Regulatory Compliance. The healthcare sector is subject to stringent government regulations and licensing requirements that may impact operational costs.
- Geographic Concentration. Operating primarily in central Gujarat exposes the company to regional economic fluctuations and localized competition.
- Talent Acquisition. The ability to attract and retain qualified medical professionals and specialists is critical to maintaining service quality.
- Operational Costs. Rising costs associated with medical equipment, pharmaceuticals, and infrastructure maintenance could pressure profit margins.
Start your research today
Unlock AI insights, financials, peers and live data on Gujarat Kidney And Super Speciality Limited and 5,000+ companies — free.
Peers · Hospital
As of Mar 2026